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ABSTRACT
Different Islamic populations have different alimentary habits, notably during Ramadan. The paper reports 
the change of diet, lipids, and lipoproteins produced during Ramadan in one Tunisian population. During 
Ramadan, the study subjects consumed more proteins, cholesterol, vitamin E (p<0.01), and polyunsatu-
rated fatty acids (p<0.05). At the same time, they exhibited an increase in total cholesterol, low-density 
lipoprotein-cholesterol (p<0.01) and apoprotein B (p<0.05) and a decrease in the ratio of apoprotein AI to 
apoprotein B (p<0.01). All assayed saturated fatty acids were unaffected by Ramadan fasting while three un-
saturated fatty acids (C18:1cis9, C18:2n-6, and C30:4n-6) increased significantly. A return to the habitual 
diet for a four-week period was not sufficient to restore the pre-fasting patterns. For the study subjects, 
Ramadan was clearly associated with a change of diet and biochemical profile but its effective impact on 
atherosclerosis risk was unclear, perhaps, because other non-alimentary changes ought to be considered 
too. Future studies considering the non-alimentary factors, such as sleep and physical activity, would be 
useful to clarify the contribution of dietary change in the observed modification of biological profile. 
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INTRODUCTION
Fasting in Ramadan is a religious practice respected by 
a large majority of Muslims, and it is associated with 
the decrease in the number of meals and the eating 
pattern which are two metabolically-active parame- 
ters (1,2). Consequently, the observed change of 
biologic profile accompanying the fast of Ramadan 
is not surprising. However, examination of data 
revealed that the impact of Ramadan fasting on 
the health is not same in different populations of 
Muslims (2-13). In particular, its impact on the 
atherosclerosis risk varies from one case to another 
of practising Muslim populations. While fasting 
is accompanied with an increase of antiatherogenic 
biochemical parameters [high-density lipoprotein-
cholesterol (HDL-cholesterol) and apolipoprotein 
(apo) AI] and/or a decrease of atherogenic param-
eters [triglycerides (TG), total cholesterol (TC), 
apoprotein (apo) B, and low-density lipoprotein-
cholesterol (LDL-cholesterol)] in certain practising 
Islamic populations (3-9), it has an opposite effect 
(10-12) or no impact (13) on other Muslim popula-
tions. This discrepancy could be attributed to dif-
ferent ethnic groups and physical activity and also 
to consumption of different alimentary products 
due to different physiopathological conditions and 
geographical zones, or different seasons in which 
Ramadan takes place. 
The role of dietary fat composition in relation to 
risk of cardiovascular diseases (CVDs) has been 
a subject of intense debate for some years. While 
high intakes of saturated fatty acids (SFAs) are 
known to raise LDL-cholesterol and atherosclerosis 
risk, intakes of polyunsaturated fatty acids (PUFAs) 
(n-6 and n-3) are inversely associated with CVDs 
(1,14,15). Barkia A et al.
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Available evidence suggests that both lipoprotein 
oxidative modification and physiological func-
tions, such as blood pressure and platelet aggrega-
tion and adhesion, are key mechanisms linked to 
the development of atherosclerosis and its associ-
ated complications, such as CVDs. These two phe-
nomena are influenced by the high intake of PUFAs. 
In fact, PUFAs are, on one hand, highly sensitive 
to oxidation (16,17), and on other hand, these are 
the precursors of active substances (prostaglandins) 
governing the platelet function and blood pressure. 
Consequently, the intake of an adequate quantity 
and/or quality of fatty acids and antioxidant nutri-
ments is necessary to combat atherosclerosis. 
The fatty acid composition of total plasma lipids is 
a reliable marker of alimentary fatty acids (18,19). 
Then, the study of the plasma fatty acid profile 
could inform us about the quality of diet. Besides, 
the existence of a relationship between patterns of 
plasma fatty acid composition and arterial stiffness 
has been reported (20). Despite the possible impact 
of the study of plasma lipid composition, stud-
ies on plasma fatty acid composition are sparse. 
Particularly, the effect of fasting in Ramadan on 
the composition of plasma fatty acids has never 
been examined. 
In Tunisia, Ramadan is always associated with an 
increased consumption of fruits, salads, eggs, milk, 
and other dairy products. The changes of diet and 
several lipid and lipoprotein parameters, including 
the pattern of plasma fatty acids, have been investi-
gated in subjects from the same area and same so-
cioeconomic level. The findings are presented in 
this paper.
MATERIALS AND METHODS
Subjects
Initially, the number of volunteer subjects was 36 
(22 males and 14 females) but only 25 (19 males 
and 6 females) aged 22-55 years completed the full 
protocol. All the subjects were from Sfax city (a 
coastal Tunisian city) and were the staff of the Fac-
ulty of Medicine or that of the hospital. All these 
subjects had a normal glycaemia and body mass in-
dex (BMI), and none of them had a history of meta-
bolic disease in their immediate family lineage.
Alimentary survey
Before Ramadan, the subjects provided a written des- 
cription of 4-6 diets. The average of these diets was 
used as the habitual one. During Ramadan, twice a 
week, each subject recorded the approximate quan-
tities of food eaten. The total Ramadan diet was the 
average of the eight recorded meals. The nutrient 
intakes were calculated using the Nutritionist IV 
Computer Analysis software (version 3.1) (Nutri-
tionist IV Computer Analysis Program, 1994, N2 
Computing, Hearst Corp. Salem, OR, USA).
Blood-collection samples
Before midday and approximately 9-10 hours af-
ter the last meal taken by the subjects, 10 mL of 
blood samples were drawn by venipuncture into 
tubes containing 0.01 mM of ethylene diamine 
tetraacetic, 2 μg/mL of sodium azoture, and 5 μg/
mL of gentamicin. Plasmas were obtained by cen-
trifugation at 3,000 rpm for 15 minutes at 6-8 °C. 
Glycaemia was determined immediately using a 
glucose oxidase method. Then, the plasmas were 
fractionated and placed at -20 °C until they were 
used again. This operation was carried out four 
times. The first time goes from two days before Ra-
madan to the first day of this month. The second 
and third samples were taken respectively after two 
weeks and four weeks of Ramadan. The fourth sam-
ple was taken one month after Ramadan.
Analysis of plasma lipids, lipoproteins, and 
apolipoproteins 
HDL fraction was obtained by precipitation of apoB-
containing lipoproteins using phosphotungstic   
acid (Bio-Merieux, France). The absence of apoB in 
this fraction was confirmed immunologically using 
ready commercially-available plates (Sebia, France). 
TG, TC, and HDL-cholesterol were quantified by 
standard enzymatic techniques with spectropho-
tometric detection. Apolipoprotein AI and B were 
quantified by electrophoretic immunodiffusion 
using ready commercially-available plates (Sebia, 
France).
Plasma fatty acid profile
The fatty acid composition of lipids was extracted 
from the plasma following the method of Folch et 
al. (21). Samples were dried up and esterified by 
heating these at 80 °C for two hours with methanol 
containing 2% concentrated H2SO4. The fatty acid 
methyl esters of each sample were injected into a 
Hewlett Packard HP 5890 Series II gas chromato-
graph (Hewlett Packard, Palo Alto, Calif) equipped 
with a flame ionization detector and a polar fused 
silica capillary column HP-Innowax with cross-
linked PEG, Carbowax 20 M (30 m × 0.25 mm ID 
and 0.25 μm as film thickness). The oven tempera-
ture was programmed to increase from 180 °C to 
250 °C at a rate of 10 °C per minute, and the injec-
tor and the detector temperature was 220 °C and 
280 °C respectively. Carrier gas was nitrogen (flow 
rate of 1 mL/minute). Each fatty acid concentration 
was expressed in absolute value (g/100 g) following Barkia A et al. Ramadan diet and atherosclerosis risk
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Table 1. Characteristics of recruited subjects: age; 
BMI, and glycaemia before Ramadan, 
end of Ramadan, and after Ramadan
Number                                                                                                                                                                25
Sex (male/female)                                                                                                                                19/6
Mean age (range)                                                                                                                            42 (22-55) years
BMI (kg/m2): BR/
ER/AR                            
26.4±4.2/27.9±
1.8/27.1±2.6
Glucose (mmol/L): 
BR/ER/AR                                                 
4.7±0.8/4.9±
0.9/4.7±0.9
AR=After Ramadan; BMI=Body mass index; 
BR=Before Ramadan; ER=End of Ramadan
an internal standard method using C17:0. Three 
injections per sample were performed.
Statistical analysis
Data were expressed as means (standard deviation). 
The average concentrations obtained in the two 
subject groups were compared using Student’s t-test 
while the percentages were compared using the χ2 
test. The differences were considered significant at 
p<0.05.
Ethical approval
A medical committee of the Sfax University Teach-
ing Hospital approved the study, and informed 
consent was obtained from each participant after a 
full explanation of the study.
RESULTS
Characteristics of study subjects
Age, BMI, and fasting glycaemia are summarized in 
Table 1. Glycaemia was absolutely unchanged while 
BMI increased from 26.4±4.2 kg/m2 to 27.9±1.8 kg/
m2. One month after Ramadan, BMI decreased but 
remained relatively higher than the pre-Ramadan’s 
BMI.
Characteristics of diets
As shown in Table 2, Ramadan fasting was associa- 
ted with an increase of the estimated total energy 
consumption (+5.6%). The intake of proteins, cho-
lesterol, and vitamin E (p<0.01) and PUFAs (p<0.05) 
increased while the consumption of carbohydrates 
decreased (p<0.01). In addition, the ratio of PUFAs 
to SFAs increased significantly (p<0.05) during Ra-
madan.
Pattern of total plasma fatty acids 
Table 3 shows that none of the quantified SFA 
changed even at the end of Ramadan. However, 
two weeks of Ramadan fasting were sufficient to in-
crease three polyunsaturated fatty acids: C18:1cis, 
C18:2n-6 (p<0.05), and C20:4n-6 (p<0.01) in a sig-
nificant way. No change of MUFA/PUFAs (49-50%) 
and of oleic acid/PUFAs (43-44%) was observed. 
The continuation of Ramadan practice more than 
two weeks did not have any additional effect. One 
month after Ramadan, these fatty acids were still 
high but the C18:1cis level did not differ signifi-
cantly from its pre-fasting values. 
Table 2. Comparison of Ramadan and habitual diets: daily energy, proteins, fats, and carbohydrate 
contribution (% of total energy) and daily intake of different fatty acids, fibre, vitamin C, 
and vitamin E
Nutrient                                                                     Ramadan diet Habitual diet
Energy (kcal/day)                                                           2,447±329 2,585±339 NS
   % of energy contributed by
      Proteins                                                                        12.2±1.8  15.6±2.0**
      Fats                                                                                 34.4±9.4 37.2±10.1
      Carbohydrates                                                               52.9±4.6 47.2±2.9**
 Nutrients intake
Cholesterol (mg/day)                                               250.9±125.2  529.0±147.3**
SFA (g/day)                                                                     28.5±8.7 31.5±8.0 NS
MUFA (g/day)                                                              47.8±13.4 49.3±13.8 NS
PUFA (g/day)                                                               20.1±11.3  30.9±8.7*
PUFA/SFA (%)                                                                  0.7±0.4 1.0±0.3*
Fibre (g/day)                                                                   16.5±4.7 18.7±6.6 NS
Vitamin E (mg/day)                                                            6.7±4.7 9.6±1.6**
Vitamin C (mg/day)                                                       53.7±46.9 45.3±20.3 NS
Values are expressed as means±standard error. *p<0.05; **p<0.01; MUFA=Monounsaturated fatty 
acid; PUFA=Polyunsaturated fatty acid; NS=Not significant; SFA=Saturated fatty acids Barkia A et al.
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Table 4. Pre-fasting, fasting, and post-fasting plasma concentrations of lipids, lipoproteins and 
apolipoproteins
Parameter                          BR                       R (2 weeks)             R (4 weeks)             AR (4 weeks)
TC                                  4.4±0.5                      4.5±0.6                   5.0±0.7**                  4.9±0.9*
TG                                  1.1±0.5                      1.1±0.5                   1.1±0.3                     1.1±0.6
HDL                               1.0±0.2                      1.0±0.2                    1.0±0.3                     1.0±0.2
LDL                                2.9±0.5                      2.9±0.9                    3.5±0.8**                  3.4±1.0*
apoAI                             1.4±0.2                      1.4±0.2                     1.3±0.2                     1.3±0.3
apoB                              0.8±0.2                      0.9±0.2*                    0.9±0.1*                    0.8±0.1
HDL/LDL                       0.4±0.2                     0.3±0.2                      0.3±0.1                     0.3±0.1
apoAI/apoB                   1.8±0.3                     1.7±0.3*                     1.5±0.4*                    1.6±0.3*
Values are expressed as means±standard error. Pre-fasting sampling was done in period included 
between two days before Ramadan and the first day of Ramadan. After fasting, sampling was done 
4 weeks after Ramadan. The two fasting times and after-fasting values were compared with the 
pre-fasting values; *p<0.05; **p<0.01; apo=apolipoprotein; AR=Post-fasting; BR=Pre-fasting; CT=Total 
cholesterol; HDL=High-density lipoprotein; LDL=Low-density lipoprotein; R=Fasting; TG=Triglycerides
Table 3. Pre-fasting, fasting, and post-fasting fatty acid patterns (μg/mL) 
Parameter                                                                                                    BR R (2 weeks)   R (4 weeks)  AR (4 weeks)
C14:0                                                            11.7±6.8 13.5±6.3 13.5±6.7 13.4±6.5
C14:1                                                                                                                                        1.3±1.8 1.6±1.8 1.2±0.8 1.1±0.9
C16:0                                           416.0±125.5 507.0±138.2 444.2±110.5 444.4±96.0
C16:1                                                        23.3±16.5 27.3±12.1 24.1±17.8 21.7±9.6
C18:0                                             124.1±30.5   139.8±35.7 132.7±25.3   121.9±25.4
C18:1 cis                                     351.8±94.3 453.2±143.2* 439.9±140.0* 402.6±87.2
C18:1 trans                                                                                              26.5±8.9   27.4±8.9 32.4±15.1 33.2±12.0
C18:2n-6                                 589.8±174.4 715.8±160.2* 702.6±145.0*    680.2±62.5*
C18:3n-3                                                                                                      12.1±18.9   14.9±8.7 12.1±4.5 11.2±7.8
C20:0                                                                                                                            2.8±1.6   3.8±3.1  3.4±1.6   2.3±1.6
C20:1n-9                                                                                                                          4.6±3.7 4.9±2.5 5.0±3.8 4.6±1.7
C20:2n-6                                                                                                                      2.4±2.9    1.3±1.2 1.1±1.0 3.5±2.9
C20:3n-6                                                                                                                    1.3±1.7    2.0±1.1 2.2±2.5 1.5±0.8
C20:4n-6                                    98.1±36.5 133.5±41.9**  146.2±51.9**  126.0±79.5*
C22:0                                                    16.2±8.4     21.3±11.4 18.5±10.7 14.6±3.3
C22:6n-3                                         114.1±49.2   128.3±36.5 134.0±89.7 126.1±48.8
C24:0                                                        16.1±7.9   28.1±20.0 22.6±10.0 25.1±20.4
Values are expressed as means±standard error. Pre-fasting sampling was done in period included between 
two days before Ramadan and the first day of Ramadan. The two fasting times and after fasting values were 
compared with the pre-fasting values. *p<0.05; **p<0.01; AR=Post-fasting; BR=Pre-fasting; R=Fasting
Lipids, lipoproteins, and apolipoprotein 
profile
TC, TG, HDL-cholesterol, LDL-cholesterol, apoAI, 
and apoB were quantified, and the HDL-cholester-
ol/LDL-cholesterol and apoAI/apoB ratios were cal-
culated. The results are presented in Table 4. Two 
weeks of Ramadan diet did not have any effect on 
the parameters of lipids and lipoproteins studied 
but fasting for one month altered the plasma lipid 
and lipoprotein profile significantly. In fact, the 
concentrations of TC, LDL-cholesterol (p<0.01), 
and apoB (p<0.05) increased. Moreover, the apoAI/
apoB and HDL-cholesterol/LDL-cholesterol values 
decreased. However, while the first ratio varied sig-
nificantly (p<0.05), the variation of the second one 
was not significant (p<0.1). One month after Ra-
madan, the lipids and lipoprotein profile had not 
normalized, and they showed the same change ob-
served at the end of Ramadan.
DISCUSSION
Dietary recommendations specify that the intakes 
of carbohydrate, proteins, and fats should provide 
50-55%, 15%, and 30% of daily energy respectively. Barkia A et al. Ramadan diet and atherosclerosis risk
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Also, an intake of fats composed of 50% of MUFAs, 
25% of PUFAs, and 25% of SFAs was recommend-
ed. Despite the minor differences, the habitual and 
Ramadan diets of this study were concordant with 
these recommendations. However, fewer carbohy-
drates and more proteins were consumed during 
Ramadan (p<0.01). Also, the Ramadan diet was 
characterized by higher levels of cholesterol, PUFAs, 
and vitamin E. The higher intakes of PUFAs and 
vitamin E could be attributed to the higher con-
sumption of raw vegetable oil, especially olive oil, 
which has high vitamin E (present at 20-75 mg/100 
g of olive oil; unpublished results) and PUFAs. Since 
cholesterol comes from animal lipids which are 
particularly rich in SFAs, the absence of change of 
these acids concomitantly to cholesterol is remark-
able. This contrast could be explained by the high 
consumption of certain alimentary products with a 
particular composition as the briks (fried eggs). Egg 
contains a high level of cholesterol, and it has more 
unsaturated fatty acids (UFAs) than SFAs (about 
two-thirds UFAs vs one-third SFAs) (22,23).    
In agreement with previous observations (2-12), 
fasting in Ramadan causes a change of biological 
and anthropometric profiles. At the end of Ra-
madan, our subjects exhibited an increase in 
BMI. This variation was not significant but it could 
be a great change of major clinical significance. In 
fact, if every person gained +1 BMI in Ramadan of 
each year, the whole population would be obese. 
Fortunately, the BMI is probably normalized after 
Ramadan as indicated by its relative decrease one 
month after Ramadan.  
A diet high in cholesterol and in fatty acids is as-
sociated with an increased risk of atherosclerosis. 
However, the real impact of alimentary fatty acids 
appears according to their nature and respective 
levels. The SFAs and trans-fatty acids (TFAs) are 
recognized favourable to CVDs while the PUFAs are 
generally considered antiatherogenic (24-28). 
However, the latter fatty acids have a complex re-
lationship with atherosclerosis. In particular, they 
become atherogenic factors if they are consumed at 
a disproportional quantity compared to SFAs and/
or insufficiently protected against the oxidative 
process. The maximal beneficial action of PUFAs 
was reported for the PUFA/SFA ratio=1 (29). In con-
nection with that, the Ramadan diet of the study 
subjects appears to be positive: first, because the 
PUFA/SFA ratio increased, and it went very close to 
the recommended value, and second, because of its 
improved potential of protection against the oxi-
dative deterioration as suggested by the increase of 
vitamin E intake. 
Several studies reported that the rates of various fat-
ty acids in plasma reflected the rate in food (30,31). 
Consistent with these data, we found that levels of 
the PUFA and PUFA/SFA ratio varied similarly in 
the diet and plasma. The increase in PUFAs was pri-
marily due to one of w6 which could express an in-
creased consumption of raw vegetable oils, mainly 
olive oil. Consistent with this idea, oleic acid also 
increased. 
It is commonly admitted that the high intake of 
alimentary SFAs, TFAs, and cholesterol is associated 
with an increase in total cholesterol, LDL-choles-
terol, and apoB concentration and/or decrease of 
HDL-cholesterol (24-27,32). As it was shown in the 
composition diets (Table 2), the intake of SFAs was 
unvaried in Ramadan. The total content of TFA in 
the diet was not determined and only C18:1trans 
was quantified in plasma. However, the fact that 
this TFA plasma level did not change during Rama- 
dan, and the fact that our subjects did not con- 
sume more processed foods which are rich in TFA 
(as margarine) suggests that the intake of TFAs did 
not vary significantly during Ramadan. So, the in-
crease of TC, LDL-cholesterol, and apoB and the 
reduction of apoAI/apoB ratio (Table 3) observed in 
our subjects during Ramadan could be attributed 
mainly to the high intake of cholesterol (33). The 
consumption of such amounts of cholesterol was 
previously associated with the formation of abnor-
mal and cholesterol-enriched LDL (17). This does 
not seem to be the case in the study subjects be- 
cause LDL-cholesterol/apoB was unchanged. Fur-
thermore, we had not observed the reduction of TC 
and TC/HDL-cholesterol ratio in response to high 
intakes of PUFAs (4,34) perhaps because of a higher 
hypercholesterolaemic effect of the consumed cho-
lesterol. However, an inadequate quantity and/or 
quality of alimentary fatty acids must be consid-
ered.  
The plasma lipid profile and CVD risk in mice are 
said to be sensitive to the diet ratio of ω6 PUFA to 
eicosapentaenoic acid (EPA, C20:5ω3) and docosa-
hexaenoic acid (DHA, C22:6ω3) [ω6/(EPA+DHA)] 
(35,36). Both n-6 and n-3 PUFAs serve as precursors 
of other important compounds. Excess of one fami- 
ly of fatty acids can interfere with the metabolism 
of the other and its overall biological effects. 
As is suggested by the increase of the ω6/ω3 ratio 
(5.46 before Ramadan and 5.84-5.96 during Rama- 
dan) in plasma lipids which reflects alimentary 
lipids (18,19), Ramadan diet could have an unfa-
vourable PUFA composition. Essentially, Ramadan 
is associated with an increased consumption of 
vegetable oil and a decrease in fish consumption.
The increase of n-6 PUFA in plasma lipids was justi-
fied by the concomitant increase of linoleic and Barkia A et al.
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arachidonic acids. The increase of these two acids 
was not surprising because they are metabolically 
linked (linoleic acid is the precursor of arachidonic 
acid). However, we must emphasize the  more  pro-
nounced change of the second fatty acid as suggest-
ed by the more significant difference between its 
habitual and its Ramadan values (p<0.01 vs p<0.05 
for C18:2n-6) and by the decrease of the C18:2n-6/
C20:4n-6 ratio which fell from about 6 before Ra-
madan to about 4.9 in Ramadan. Such an obser-
vation could be attributed, at least in part, to the 
activation of the linoleic acid to arachidonic acid, 
especially the absence of linolenic acid (C18:3 n-3), 
which is able to inhibit this conversion (37).
Now, it is well-known that the atherosclerotic proc-
ess involves many and various mechanisms which 
are influenced by lipids or their derivatives. For ex-
ample, the pattern of fatty acids (FAs) could affect 
the atherosclerosis risk by affecting the blood fluidi- 
ty which depends on the production of prostaglan-
dins obtained from arachidonic acid (ω6). Also, the 
FA pattern, particularly the level of AA, has been re-
ported to be important for the elasticity of arteries 
(38). An observed increase of n-6 in plasma could 
signify an adequate production of prostaglandins 
and correct elasticity of arteries and, then, a de-
crease of both blood clotting and calcification of 
arteries. On the other hand, high levels of PUFAs 
could be favourable to the atherogenic process. For 
example, they could stimulate the formation of 
adipocyte as it was in mouse (39) and, consequently, 
induce obesity, which is associated with a high risk 
of CVDs. Also, because PUFAs are highly sensitive 
to the oxidation process, the increase of their lev-
els could be associated with an increased oxidative 
modification of LDL which becomes more athero-
genic (40). However, this situation was not obliga-
tory in our subjects because the concomitant higher 
intake of vitamin E could lead to a relative protec-
tion. In addition, in recent work, Mauerer et al. ob-
served that linoleic acid reduced the ABCA1 and 
ABCG1 expression in M-CSF predifferentiated mac-
rophages, and they concluded that it was associa- 
ted with an increase of the formation of athero-
sclerotic lesions by diminishing the reverse cho-
lesterol transport function of ABCA1 and ABCG1 
(41). Finally, PUFAs affect the expression of genes 
controlling the inflammatory process which char-
acterizes the atherosclerosis. In this respect, the n-6 
and n-3 families of PUFAs appear to have opposing 
and antagonistic effects. While n-3 PUFA increases 
the cells resistant to inflammation by eliminating 
the expression of inflammatory genes, n-6 PUFA 
exerts the opposite effect (42).
Considering the total data, the ratio of n-3 PUFA 
to n-6 PUFA appears as a determining factor for the 
protective role which has been proposed as an im-
portant index of cardiovascular risk. Based on the 
plasma fatty acid profile, this ratio may suffer an 
adverse change in Ramadan.
The return to habitual diet tends to restore the 
normal lipid and lipoprotein profile. However, 
the change, caused by Ramadan fasting, does not 
disappear four weeks after. It is possible that some 
eating and/or non-eating habits in Ramadan per-
sist for some time later. A study of subjects during 
a longer time after Ramadan could have been very 
beneficial but it was difficult to retain the studied 
subjects for a longer period.
The interpretation of our results is delicate. Alth- 
ough the high intake of both vitamin E and PUFAs 
could have beneficial effects, the change of plasma 
lipid and lipoprotein profile was atherogenic (in-
crease of plasma TC, LDL-cholesterol, apoB, and 
ω6/ω3). 
In this paper, we provide evidence for the com-
plexity of the relationship between Ramadan diet 
and the health state, particularly with atheroscle-
rosis risk. To know the real effect of our subjects’ 
Ramadan fasting model, it is notably necessary to 
study other parameters [Lp(a), apoAI-containing li-
poproteins, TFAs, oxidant status, LDL size, etc.] and 
physiological functions (blood coagulation, plate-
lets function, apoB-receptor activity, cholesterol ef-
flux, etc.). 
The knowledge about the effective impact of Rama- 
dan fasting could be of great interest for possible 
intervention to correct the Ramadan diet of certain 
populations of practising Muslims.
The comparison of the dietary changes in different 
Islamic populations and of their impact on vari-
ous biological and biochemical parameters may be 
a valid approach in determining a diet model to 
be followed by Muslims and to advise even non-
Muslims. 
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